AD-5423 versus haloperidol in the treatment of schizophrenic patients: Results of the Japan multicentre, double-blind trial

被引：0
|
作者：
Murasaki, M [1 ]
机构：
[1] Kitasato Univ, Sch Med, Sagamihara, Kanagawa 228, Japan
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S268 / S268
页数：1
相关论文
共 50 条
  • [21] A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients
    Breitbart, W
    Marotta, R
    Platt, MM
    Weisman, H
    Derevenco, M
    Grau, C
    Corbera, K
    Raymond, S
    Lund, S
    Jacobsen, P
    AMERICAN JOURNAL OF PSYCHIATRY, 1996, 153 (02): : 231 - 237
  • [22] A DOUBLE-BLIND CONTROLLED TRIAL OF PIPOTIAZINE, HALOPERIDOL AND PLACEBO IN RECENTLY-HOSPITALIZED ACUTE SCHIZOPHRENIC-PATIENTS
    BECHELLI, LPC
    RUFFINONETTO, A
    HETEM, G
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1983, 16 (04) : 305 - 311
  • [23] Olanzapine versus placebo and haloperidol: Quality of life and efficacy results of the North American double-blind trial
    Hamilton, SH
    Revicki, DA
    Genduso, LA
    Beasley, CM
    NEUROPSYCHOPHARMACOLOGY, 1998, 18 (01) : 41 - 49
  • [24] Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial
    Beasley, CM
    Tollefson, G
    Tran, P
    Satterlee, W
    Sanger, T
    Hamilton, S
    Fabre, L
    Small, J
    Ereshefsky, L
    True, J
    Nemeroff, C
    Risch, SC
    Perry, PJ
    Potkin, SG
    Borison, RL
    James, S
    Meltzer, HY
    Iqbal, N
    Fann, WE
    Gewirtz, GR
    Landbloom, R
    RoyByrne, PP
    Tuason, VB
    Carman, JS
    Stokes, PE
    Williams, R
    Ancill, RJ
    MacEwan, GW
    Gujavarty, KS
    Jones, B
    Lohr, JB
    NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) : 111 - 123
  • [25] Olanzapine versus placebo and haloperidol: Quality of life and efficacy results of the North American double-blind trial
    Hamilton S.H.
    Revicki D.A.
    Genduso L.A.
    Beasley Jr. C.M.
    Neuropsychopharmacology, 1998, 18 (1) : 41 - 49
  • [26] Amisulpride versus risperidone in the treatment of schizophrenic patients: A double-blind pilot study in Taiwan
    Hwang, TJ
    Lee, SM
    Sun, HJ
    Lin, HN
    Tsai, SJ
    Lee, YC
    Chen, YS
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2003, 102 (01) : 30 - 36
  • [27] DRUG TREATMENT OF ADOLESCENT TIQUEURS - A DOUBLE-BLIND TRIAL OF DIAZEPAM AND HALOPERIDOL
    CONNELL, PH
    CORBETT, JA
    HORNE, DJ
    MATHEWS, AM
    BRITISH JOURNAL OF PSYCHIATRY, 1967, 113 (497) : 375 - &
  • [28] DOUBLE-BLIND COMPARATIVE-STUDY OF REMOXIPRIDE AND HALOPERIDOL IN ACUTE SCHIZOPHRENIC-PATIENTS
    DENBOER, JA
    RAVELLI, DP
    HUISMAN, J
    OHRVIK, J
    VERHOEVEN, WMA
    WESTENBERG, HGM
    PSYCHOPHARMACOLOGY, 1990, 102 (01) : 76 - 84
  • [29] Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients
    Ulferts, J
    Hagenhoff, M
    Krieger, S
    Gallhofer, B
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 269 - 269
  • [30] Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms:: A randomized double-blind multicenter trial
    Möller, HJ
    Riedel, M
    Müller, N
    Fischer, W
    Kohnen, R
    PHARMACOPSYCHIATRY, 2004, 37 (06) : 270 - 278
12345